|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1993-8-31
|
|
pubmed:abstractText |
The existence of a tumor-specific T-cell immune response to human malignant melanoma has been well documented. In contrast, the existence of tumor-specific cytotoxic T lymphocyte to ovarian cancer remains controversial despite the abundant lymphocytic infiltrates in the malignant ascites and solid tumor of these patients.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0039-6060
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
114
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
227-34
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8342128-Adult,
pubmed-meshheading:8342128-Aged,
pubmed-meshheading:8342128-Antibodies, Monoclonal,
pubmed-meshheading:8342128-Cytotoxicity, Immunologic,
pubmed-meshheading:8342128-Female,
pubmed-meshheading:8342128-Humans,
pubmed-meshheading:8342128-Lymphocytes, Tumor-Infiltrating,
pubmed-meshheading:8342128-Middle Aged,
pubmed-meshheading:8342128-Ovarian Neoplasms,
pubmed-meshheading:8342128-T-Lymphocytes,
pubmed-meshheading:8342128-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:8342128-Tumor Cells, Cultured
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
T-cell recognition of ovarian cancer.
|
|
pubmed:affiliation |
Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass. 02115.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
